Provided by Tiger Trade Technology Pte. Ltd.

Replimune Group Inc.

13.07
-0.3800-2.83%
Post-market: 13.200.1262+0.97%19:54 EDT
Volume:1.30M
Turnover:17.12M
Market Cap:1.23B
PE:-4.14
High:13.83
Open:13.69
Low:12.80
Close:13.45
52wk High:16.33
52wk Low:1.50
Shares:94.22M
Float Shares:77.49M
Volume Ratio:0.48
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1550
EPS(LYR):-3.3828
ROE:-134.29%
ROA:-51.30%
PB:11.66
PE(LYR):-3.86

Loading ...

Replimune downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
Apr 11

Sector Update: Health Care Stocks Lower Friday Afternoon

MT Newswires Live
·
Apr 11

Replimune CRL positive for Iovance in near-term, says Chardan

TIPRANKS
·
Apr 11

Top Midday Decliners

MT Newswires Live
·
Apr 11

BRIEF-FDA Says Data Insufficient To Conclude Effectiveness Of Replimune's vusolimogene oderparepvec

Reuters
·
Apr 11

Replimune Stock Tumbles After FDA Rejects Skin Cancer Therapy for Second Time -- Barrons.com

Dow Jones
·
Apr 11

Replimune's Biologics License Application for Advanced Cutaneous Melanoma Drug Rejected by FDA

MT Newswires Live
·
Apr 11

Replimune Group's Drug for Advanced Cutaneous Melanoma Rejected by FDA

MT Newswires Live
·
Apr 10

Replimune issued Complete Response Letter for RP1 for advanced melanoma

TIPRANKS
·
Apr 10

FDA, in Complete Response Letter: Data Was Insufficient to Conclude Substantial Evidence of Effectiveness of Replimune's Vusolimogene Oderparepvec

THOMSON REUTERS
·
Apr 10

US FDA declines to approve Replimune's drug for advanced skin cancer

Reuters
·
Apr 10

Replimune sinks after FDA issues complete response letter

TIPRANKS
·
Apr 10

Replimune halted for news after dropping 19% to $4.76

TIPRANKS
·
Apr 10

Replimune Group trading halted, volatility trading pause

TIPRANKS
·
Apr 10

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:53 AM

Reuters
·
Apr 10

FDA Review Looms As Replimune Faces Weak Technical Setup

Benzinga_recent_news
·
Apr 09

Replimune Chief Commercial Officer Christopher Sarchi sells USD 52,065 common shares

Reuters
·
Apr 07